跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 85,792 条关于
“Claudin 18.2-targeted therapy”
全部
85,792
临床试验
57,977
药物
5,301
机构
160
资讯
22,354
去年
Claudin 18.2-Targeted Therapies Show Promise in Gastric and Other Cancers
去年
Vyloy Leads Claudin 18.2 Targeted Therapy Revolution with 60+ Drug Candidates in Pipeline
7个月前
Claudin 18.2 Targeted Therapy Market Set to Exceed $800 Million by 2030 as Pipeline Expands Beyond Gastric Cancer
去年
Vyloy Approval in Korea Faces Reimbursement Hurdles Despite Clinical Promise
去年
FDA Grants Priority Review to Astellas' Zolbetuximab for Gastric and GEJ Adenocarcinoma
去年
China's Biopharma Sector Showcases Innovation Leadership at BIOSeedin 2025 Conference
去年
Triumvira Immunologics Presents Promising Phase 1 Data for TAC101-CLDN18.2 in Solid Tumors
4年前
I-Mab's TJ-CD4B Receives FDA Orphan Drug Designation for Gastric Cancer Treatment
去年
FDA Approves Zolbetuximab for Claudin 18.2-Positive Gastric and Gastroesophageal Junction Cancers
2年前
Elevation Oncology's EO-3021 Shows Promise in Claudin 18.2-Expressing Solid Tumors
第 1 页,共 2236 页
上一页
下一页